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Abstract Recently, our research group has proposed the
hydroxyfurazanyl (4-hydroxy-1,2,5-oxadiazole-3-yl) moiety
as a new non-classical isoster of the carboxy function in the
design of γ-aminobutyric acid (GABA) analogues. Some
compounds showed significant activity at the GABAA
receptor, representing the only examples of pentatomic
heterocycles bearing an ω-aminoalkyl flexible side chain in
the position vicinal to the hydroxy group displaying agonist
activity at this receptor subtype. In this work, an ab initio
analysis of the structural and electronic features of furazan-3-
ol is presented, in order to provide a theoretical basis to the
claimed bioisosterism with the carboxy function. An ab
initio conformational study with the C-PCM implicit solvent
model was carried out to elucidate the reasons of the peculiar
behaviour of the furazan models. Alongside, another
conformational search through molecular dynamics in
explicit solvent was accomplished, in order to validate the
first method. The electronic features of the 4-hydroxy-1,2,5-
oxadiazole-3-yl substructure seem to account for a marked
stabilising effect of the putative bioactive conformation at the
GABAA receptor subtype. The 1,2,5-thiadiazole analogue,
which shares the same conformational preference of its
oxygenated counterpart, was identified as a potential
candidate for synthesis and pharmacological testing.
Keywords Carboxyl group isoster . GABAA receptor .
1, 2, 5-oxadiazole . Furazan
Introduction
Isosteric replacement of functional groups is one of the
classical pharmacomodulation approaches used in medici-
nal chemistry to improve the safety and activity profile of a
lead compound [1]. When the replacement results in
compounds sharing with the lead similar physicochemical
and biological properties, then the groups are called
bioisosters [2, 3]. Several examples of bioisosteric replace-
ments are known in the literature; in particular, the carboxyl
group has been successfully substituted by hetero- and
carbocycles such as tetrazole, 3-hydroxyisoxazole, 3-
hydroxyisothiazole, 3-hydroxy-1,2,5-thiadiazole and 3-
cyclobutene-1,2-dione. These ring systems have been
widely employed in the design of centrally active amino
acid mimetics. Recently, the hydroxyfurazanyl (4-hydroxy-
1,2,5-oxadiazole-3-yl) moiety has been proposed by our
research group as a new non-classical isoster of the
carboxyl group [4, 5]. When this ring system was used in
the design of a series of analogues of γ-aminobutyric acid
(Fig. 1), indeed it proved to behave as a bioisoster of the
carboxy function [5].
Derivatives 1 and 2 showed moderate activity on
GABAA receptor as partial agonists, while 3 was a weak
ligand, with mainly antagonistic properties (Table 1).
Larsen and co-workers have synthesised throughout the
years a large number of GABAA ligands, which allowed
the elucidation of structure-activity relationships and the
progressive refinement of a 3D-pharmacophore model [6].
This model provides a sound explanation of the activity
profile of the isoxazolol models THIP (4a), 4-PIOL (5a),
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muscimol (6a) (Fig. 2), as well as of their respective
isothiazolol analogues 4b–6b. While homologation of
muscimol and expansion of the THIP piperidine ring
afforded derivatives which retain GABAA agonism (homo-
muscimol, 7 [7]; THAZ, 8 [8]), changing the position of the
protonated nitrogen inside the ring (THPO, 9 [9]; THIA, 10
[8]) resulted in inactive compounds. Substitution at the ring
position vicinal to the hydroxyl group is allowed when
giving rise to fused systems (4a–b, 8), while in open-chain
ligands (4-methylmuscimol, 11; AEMI, 12; 13) it is always
accompanied by loss of affinity [6]. This pattern of
substitution is tolerated only for derivatives of 4-PIOL
and its sulphur congener (5a–b), for which a different
binding mode, made possible by a conformational shift of
an arginine residue in the receptor, has been proposed [10,
6]; notably, all such compounds behave as potent antago-
nists. To the best of our knowledge, 1 and 2 represent the
only examples of pentatomic heterocycles bearing an ω-
aminoalkyl flexible side chain in the position vicinal to the
hydroxyl group displaying agonist activity at the GABAA
receptor.
In order to provide a theoretical basis to the claimed
bioisosterism, in the present work structural and electronic
features of furazan-3-ol 16 were compared with those of the
carboxyl group present in acrylic acid 17 and of its isoxazol
congener 18 (Table 2). Then, a conformational study was
carried out to shed light on the peculiar behaviour of the
furazan models 1–3.
Methods
3D models of structures 16–18 (Table 2) were built from
standard bond lengths and angles with the MOE modelling
suite [11]. Their geometries were optimised in vacuum with
Cs symmetry using ab initio methods at two different levels
of theory, HF/6–31G(d) and MP2/6–311G(d,p), until the
largest component of the gradient was less than 1·10–5
Hartree Bohr–1. The stationary points were characterised as
true minima through vibrational analysis (no imaginary
frequencies), then single-point calculations at the same
level of theory were run in order to calculate the dipole
moment and atom-centred ESP-derived charges (CHELPG
method). All quantum-mechanical (QM) calculations were
accomplished with the GAMESS-US package [12].
The 3D models of compounds 1–3, 12, 14, 15 (Figs. 1, 2,
3) were built in their zwitterionic form from standard bond
lengths and angles with MOE, while for compounds 4a–b
the crystallographic coordinates were available [13, 14]. All
structures were optimised by a RHF/6–31G+(d) ab initio
Fig. 1 4-(ω-aminoalkyl)-1,2,5-
oxadiazole-3-ol analogues of
GABA [5]
Table 1 Binding affinities at the GABAA receptor [5]
a
Compd [3H]muscimol binding Ki (μM)
GABA 0.049 (0.043, 0.056)
4a (THIP) 0.16
5a (4-PIOL) 9.1 (8.2, 10)
1 13 (11, 16)
2 27 (25, 30)
3 >100
a Standard receptor binding on rat brain synaptic membranes, n=3.
Mean and SEM were calculated assuming a normal distribution of the
logarithm of the Ki values. Numbers in parentheses (min, max)
indicate the antilog of the log of the mean ± SEM of Ki.
Fig. 2 GABA-like structures used as pharmacological tools or to
elucidate structure-activity relationships
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method setting the convergence criterion at 1·10–4 Hartree
Bohr–1. Solvent effects were included using the polarisable
continuum model C-PCM as implemented in GAMESS-US
[15, 16].
On compounds 1, 12, 14, 15 a systematic ab initio
torsional search was carried out at the same level of theory
used for the initial optimisation, by means of a two-step
procedure. In the first step the two torsional angles C3-C4-
C6-C7 (φ) and C4-C6-C7-C8 (y) (see Fig. 4) were varied
Table 2 Calculated properties for compounds 16–18 (MP2/6–311G(d,p) level)
a CHELPG ESP-derived charges are reported near each atom; the green arrow represents the dipole moment vector (debye), pointing from the
positive charge to the negative charge according to the convention followed in [21]. Figures were realised with the aid of the Gabedit package
[22].
Fig. 3 Isoxazole and 1,2,5-thiadiazole analogues of compound 1
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over 15° increments, obtaining 576 possible conformers,
coupled in 288 enantiomeric pairs since the planar
pentatomic ring represents a plane of simmetry. The
generated conformers underwent a constrained geometry
optimisation freezing the two selected dihedrals at the
initial values, while allowing the other internal coordinates
free to relax, using a rather loose convergence criterion
(1·10–3 Hartree Bohr–1). This first step allowed thorough
sampling of the potential energy surface (PES), in order to
identify the range of the selected dihedrals giving rise to
energetically accessible conformers in a 5-kcal range from
the global minimum (Fig. 4).
On these conformers, a second unconstrained minimisation
step was performed, this time with a tight convergence
criterion (1·10–5 Hartree Bohr–1), which made most of the
conformers found in the first step coalesce into the same
local minima, thus reducing the number of possible
minimum energy conformations to a few (see Tables 3, 4
and Fig. 5). Vibrational analysis allowed characterising the
stationary points as true minima (no imaginary frequencies).
Zero-point vibrational energies were scaled by a factor of
0.9153, while factors of 0.8945 and 0.9027 were adopted for
the thermal contributions to enthalpy and entropy respec-
tively, as suggested by Scott and Radom for the RHF/6–
31G+(d) basis set [17]. The free energy of each conformer in
aqueous solution was calculated according to Eq. 1 as the
sum of Eele (total electronic energy), Ezp (zero-point energy),
Gtherm (thermal contribution to enthalpy and entropy at
Fig. 4 Potential energy surfaces (PES) for compounds 1 (a), 12 (b),
14 (c), 15 (d). The potential energy (kcal mol–1) is reported on the z
axis vs the values of the dihedral angles φ, y (degrees). The energy
values lying in a 5-kcal range from the global minimum have been
painted in grey on the 3D plot, while the corresponding φ, y ranges
have been projected on the xy plane as grey areas. A 20-kcal cutoff has
been adopted in the plot in favour of a more detailed rendering of the
minima
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298.15 K) and Gsolv (solvation free energy, calculated by the
C-PCM method).
Gtotaq ¼ Eele þ Ezp þ Gtherm þ Gsolv ð1Þ
The results have been reported as the difference in free
energy between each conformer and the global minimum.
On compounds 2, 3 the first step was not performed by
an ab initio systematic torsional scan, since the number of
conformers (6912 and 165888 enantiomeric pairs, respec-
tively) would have been computationally untreatable with
QM ab initio methods. A stochastic search was instead
accomplished with the StochasticCSearch module imple-
mented in MOE, using the MMFF94s force field. Solvent
effects were modelled according to the generalised Born/
surface area (GB/SA) approach, setting the dielectric
constants for the molecule and bulk water to 1 and 80,
respectively, with no cutoff for non-bonded interactions;
atom-centred charges were fit to the ab initio electrostatic
potential through the RESP procedure [18]. Each conformer
was minimised until the RMS gradient was lower than
1·10–3 kcal mol–1. Conformations were rejected if the RMS
deviation from already existing ones was lower than 0.5 Å,
or if their energy was more than 7 kcal above the global
minimum. A maximum of 104 iterations were performed on
each molecule, and the search was abandoned after 1000
consecutive failures to find a new conformer. The search
was repeated 10 times to make sure that all low energy
conformers had been found. After choosing one enantiomer
from enantiomeric conformer pairs, 9 conformers were
identified for compound 2, 21 for compound 3. These
conformations underwent full ab initio geometry optimisa-
tion with a 1·10–5 Hartree Bohr–1 convergence criterion,
and were then characterised as true minima by means of
vibrational analysis as previously described. The conforma-
tions exceeding a 5-kcal threshold from the global
Table 3 Stable conformers of compounds 1, 12 (ab initio C-PCM systematic search)
a Free energy relative to the global minimum for each cluster of conformers, expressed in kcal mol−1 ; see Methods section for the details of the
QM calculation.
b Expressed in degrees (see Fig. 4 for the definition of φ and y).
c RMSD from the crystallographic coordinates of 4a, calculated in Å over all heavy atoms.
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minimum were discarded; the remaining ones are listed in
Table 5.
On compounds 1–3, 12, 14, 15 another conformational
search through molecular dynamics (MD) was carried out,
modelling the solvent explicitly. To this purpose, a random
starting conformer was soaked in a cubic water box with a
30.28 Å side using the water soak facility implemented in
MOE; the ligand and water coordinates were then imported
into CHARMM [19]. The MMFF parameters were used
throughout the simulations along with the MMFF-specific
vtrunc method of evaluating non-bonded interactions.
Particle mesh Ewald periodic boundary conditions were
chosen (dielectric constant = 1.0), setting cutim, ctvtrn,
cutnb, ctonnb, ctofnb cutoff parameters to 14.0, 12.0, 14.0,
10.0 and 12.0 Å, respectively. Non-bonded and image lists
were updated when necessary (heuristic test). Before MD,
starting coordinates were minimised with a loose conver-
gence criterion of 0.01 kcal mol−1 Å−1 according to the
adopted basis Newton-Raphson method in three steps:
firstly, the solute coordinates were restrained with a
harmonic constraint of 1.0 kcal mol−1 Å−2; then, the
constraint was removed from the solute and put on water
molecules; finally, all constraints were removed and full
relaxation was allowed. Molecular dynamics were carried
out constraining all bonds involving hydrogen with the
SHAKE algorithm. Firstly, the system was gradually heated
Table 4 Stable conformers of hypothesised models 14, 15 (ab initio C-PCM systematic search)
a Free energy relative to the global minimum for each cluster of conformers, expressed in kcal mol−1 ; see Methods section for the details of the
QM calculation.
b Expressed in degrees (see Fig. 4 for the definition of φ and y).
c RMSD from the crystallographic coordinates of 4a, calculated in Å over all heavy atoms.
d RMSD from the crystallographic coordinates of 4b, calculated in Å over all heavy atoms.
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at constant pressure from 0 to 300 K over 50ps (time step
0.2 fs), constraining all atoms with a force constant of
5.0 kcal mol−1 Å−2. Then, the constraint was reduced to
1.0 kcal mol−1 Å−2 and 50 ps of constant pressure dynamics
at a constant temperature of 300 K were run (time step
0.5 fs, Hoover algorithm). Further 50 ps of constant p/T
equilibration (time step 1.0 fs) with no constraints were
carried out in order to let the system achieve the correct
density. Afterwards, constant V/T conditions were chosen
(time step 1.0 fs, Nosé-Hoover algorithm), setting the
periodic box size as the average size during the last 25 ps of
the previous constant p/T equilibration trajectory. After a
50-ps equilibration run, a production run of 1 ns was
accomplished, using the multi-heat bath method as imple-
mented in CHARMM: while bulk water was kept at 300 K,
the solute was coupled with a 600 K heat bath, in order to
overcome easily rotational barriers and achieve thorough
conformational sampling. The 200 conformers were
extracted from the trajectory at 5-ps intervals; since large
deviations from equilibrium geometries are to be expected
running MD at high temperature, all solvated conformers
were minimised according to the procedure described
previously, but with a tighter convergence criterion of
1.0·10–4 kcal mol−1 Å−1. Water molecules were stripped off
the 200 minimised snapshots and a molecular database was
built in MOE out of the naked solute conformers. Duplicate
conformers (heavy-atom RMSD threshold = 0.2 Å) and
mirror images were removed, then on the remaining
geometries a potential energy evaluation was carried out
with the GB/SA method as implemented in MOE, as
previously described. The whole MD process was repeated
five times starting from different random conformations; for
all compounds the results were almost identical over the
five runs and are reported in Table 6 for compound 1. Data
concerning compounds 2, 3, 12, 14, 15 can be found in the
Electronic supplementary material (Tables 7, 8, 9, 10, 11).
The isodensity surfaces represented in Fig. 6 were
generated with MOLDEN [20] from GAMESS output files.
The electron density was evaluated on an evenly spaced
cubic grid with a 20 Å side and a 0.2 Å mesh, then
contoured at 0.07 e Bohr–3 level. The electrostatic potential
was evaluated on the same points as the electron density
and colour-mapped on the isodensity surface. All calcu-
lations were run on a Linux cluster composed of 24 CPUs
(Pentium IV single core, clock frequency ranging from 1.6
to 3.2 GHz).
Results and discussion
In order to substantiate with theoretical data our claim of
bioisosterism between the hydroxyfurazanyl moiety and the
carboxyl group, we calculated structural and electronic
features of furazan-3-ol 16 with ab initio methods, extend-
ing the analysis also to its isoxazol congener 18. As a
representative planar molecule containing the carboxyl
group, acrylic acid 17 was chosen (Table 2). Since both
crystallographic and theoretical data are available for 18
[21], the same levels of theory chosen by Frydenvang and
co-workers were used to allow results comparison. Both
dipole moments and CHELPG ESP charges reported in [21]
Fig. 5 Superposition between: a, b) the putative bioactive conformer
of 1, 2 (light colours) and the crystallographic conformation of 4a
(intense colours, RMSD=0.23, 0.27 respectively); c) the putative
bioactive conformer of 15 (light colours) and the crystallographic
conformation of 4b (intense colours, RMSD=0.19). Non-polar hydro-
gens have been omitted for clarity. This figure, as well as the ones
embedded in Tables 3, 4, 5, 6 and 7, 8, 9, 10, 11 (Electronic
supplementary material), was realised with PyMOL [25]
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for 18 could be almost exactly reproduced at the HF/6–31G(d)
level, while small differences were noticed at the MP2/
6–311G(d,p) level, probably connected with different
convergence criteria in SCF iterations and geometry
optimisations. Only MP2/6–311G(d,p) data will be dis-
cussed for simplicity, since they were found to mimic more
closely crystallographic geometries [21]; HF/6–31G(d) data
are reported in the Electronic supplementary material
Table 5 Stable conformers of compounds 2, 3 (MM GB/SA stochastic search)
a Free energy relative to the global minimum for each cluster of conformers, expressed in kcal mol−1 ; see Methods section for the details of the
QM calculation.
b Expressed in degrees (see Fig. 4 for the definition of φ and y).
c RMSD from the crystallographic coordinates of 4a, calculated in Å over the ring atoms and the charged terminals.
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(Table 2a). The hydroxyfurazanyl moiety displays acidic
properties: 4-propylfurazan-3-ol has a pKa of 3.77, while
the acidic pKa for compounds 1–3 ranges from 3.12 to 3.56
[5]; the overall acidic character is somewhat more marked
than for isoxazol-3-ol ligands (THIP, pKa=4.4; muscimol,
pKa=4.8 [14]), and is nearer to that of the carboxyl group in
GABA (pKa=4.04 [5]). Analysing the structural data
reported in Table 2, a close resemblance in the geometry
Table 6 Stable conformers of compound 1 (explicit solvent MD search)
a Free energy relative to the global minimum for each cluster of conformers, expressed in kcal mol 1 ; ΔG values were calculated with a MM GB/
SA method (see Methods section for details).
b Expressed in degrees (see Fig. 4 for the definition of φ and y).
c RMSD from the crystallographic coordinates of 4a, calculated in Å over all heavy atoms.
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of the H(1)-O(1)-C(1)-N(1) “carboxy-like” substructure
between the furazan and isoxazol systems is evident
(RMSD=0.018 Å); both substructures in 16 and 18 are
highly superimposable with the corresponding atoms in 17
(RMSD=0.048 and 0.040 Å, respectively). The van der
Waals volume of 16 (64.62 Å3) is a bit lower than that of 18
(72.75 Å3), due the smaller radius of nitrogen compared to
carbon and to the absence of the H(3) hydrogen atom.
When electronic features are compared, rather marked
differences emerge between the furazan-3-ol on one side
and the carboxylic and isoxazolic counterparts on the other.
While the latter two share substantially the same electronic
distribution on the H(1)-O(1)-C(1)-N(1) “carboxy-like”
substructure, as evidenced by the values of ESP-derived
charges and by the direction and intensity of the dipole
moment vector, in the furazan-3-ol system the presence of
an additional electronegative nitrogen induces a number of
changes. While the hydroxyl bond is almost identical in
the three systems, the C(1)-N(1) bond in 16 is less strongly
polarised than in 18, and therefore it mimics less closely the
carbonyl bond of the carboxyl group. Even more impor-
tantly, the polarity of the C(2)-N(2) bond in 16 is reversed
with respect to the corresponding C(2)-C(3) bond in 18.
While in the isoxazol-3-ol the C(3) atom is electropositive
due to σ-withdrawal by the vicinal O(2) atom and to the
increased charge on C(2) amenable to π-donation by O(2),
in the furazan-3-ol the corresponding N(2) atom is
characterised by a negative charge (–0.32), just a bit lower
than the one on N(1) (–0.39); by contrast, the C(2) atom is
mildly electropositive. The overall effect is that, compared
to 17 and 18, the dipole moment in 16 is almost double in
intensity and its direction is rotated leftwards by 58.6° and
77.1° respectively, pointing in the C(1)→O(2) direction.
While for compounds 1–3 the different electronic distribu-
tion may impact negatively on the affinity of the H(1)-O(1)-
C(1)-N(1) “carboxy-like” substructure for the receptor, it
could impart a peculiar conformational profile to the amino-
alkyl side chain. Since all pentatomic heterocycles showing
agonist activity at the GABAA receptor bearing a substituent
in the position vicinal to the hydroxyl group are charac-
terised by having the aminoalkyl sidechain constrained in a 6
or 7-term ring (e.g. compounds 4a b and 8, Fig. 2), we
speculated that the bioactive conformation of compounds 1,
2 could resemble that of their closed-ring congeners. It can
be easily predicted that AEMI (12) can hardly assume a
THIP-like conformation due to steric hindrance of the 5-
methyl substituent, thus failing to activate the GABAA
receptor. To verify this hypothesis, we performed a system-
atic torsional scan on compounds 1, 12 in order to explore
their PES. Similarly to GABA, 4-(ω-aminoalkyl)-1,2,5-
oxadiazol-3-ol and 4-(ω-aminoalkyl)-iso(oxa,thia)zol-3-ol
derivatives exist predominantly as zwitterions at physiolog-
ical pH [5, 10]. Since modelling multiply charged com-
pounds with molecular mechanics (MM) can lead to
overestimation of the electrostatic contribution, various
strategies have been adopted. Larsen and co-workers carried
out MM conformational searches (GB/SA model, MM3
force field) on the N-protonated form of 4-PIOL derivatives,
treating the hydroxy group as unionised, since the oxyanion
in its bioactive form is known to be hydrogen-bonded to an
Fig. 6 Electrostatic potential of
1, 14, 15 colour-coded on the
isodensity surface (contoured at
0.07 e Bohr–3). The electrostatic
potential on the surface ranges
from 0.1487 to 0.7975 Hartree;
the colour scale has been chosen
accordingly
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arginine residue in the receptor [10]. Lorenzini and co-
workers obtained good results performing a PM3 torsional
scan on the zwitterionic molecules, modelling the solvent
with an Onsager approach [23]. Since we were interested in a
highly reliable estimation of electrostatics, which are likely
to play a key role in the conformational preferences of the
compounds under study, we decided to employ an ab initio
RHF method, modelling water as a continuum with the
C-PCM method [24]. We chose the 6–31G+(d) basis set as a
good compromise between computational speed and accura-
cy; both polarisation and diffuse functions were included to
properly account for the zwitterionic status of the molecules.
In Fig. 4a, 4b the PES for compounds 1, 12 is reported, as
obtained from the first minimisation step (see Methods
section); as already pointed out, the presence of a plane of
symmetry is due to the fact that each conformer exists as an
enantiomeric pair. Once the ranges of dihedrals φ, y giving
rise to conformers in a 5-kcal energy span from the global
minimum were identified, full unconstrained minimisation
allowed to identify a few stable conformers, whose structures
and energies relative to the global minimum are reported in
Table 3. For both compounds the most stable conformation
is the one in which a charge-enhanced hydrogen bond takes
place between the oxyanion and the ammonium cation.
However, for compound 1 the conformation nearest to the
global minimum (+3.18 kcal) mimics very well the
conformation of THIP determined by X-ray crystallography
(Fig. 5a, heavy atom RMSD=0.23 Å).
This finding provides a sound explanation to the agonist
activity of 1, which however is 100-fold lower than that of
THIP, since according to QM calculations the THIP-like
bioactive conformation is not the most populated. More-
over, the loss of conformational degrees of freedom upon
binding accounts for an unfavourable entropic contribution
which is detrimental to the activity of the flexible
compound 1 with respect to the rigid one 4a. Finally, the
inverted polarisation of the C(1)-N(1) bond (Table 2) may
account for a lower affinity of the “carboxy-like” substruc-
ture for the receptor. Moving to compound 12, in the
conformation nearest to the global minimum (+3.54 kcal)
the ammonium cation is forced to lie much farther from the
isoxazole ring (heavy atom RMSD=0.82 from 4a), due to
the steric hindrance of the methyl group, while THIP-like
conformations are not energetically accessible (Table 3).
Since such a result for compound 12 was largely
expected, we wanted to elucidate if the THIP-like confor-
mation assumed by 1 is just a consequence of the absence
of hindering substituents in 5-position on the ring, or if it is
amenable to the peculiar electronic features of the 1,2,5-
oxadiazole system; if so, we were interested in knowing if
the 1,2,5-thiadiazole analogue could eventually share such
features. To this purpose, the 3D models of two structures
were built, namely the 5-demethyl analogue of AEMI 14
and the thiadiazole 15, both of which are not known in the
literature (Fig. 3). The same ab initio torsional scan was
performed as for 1 and 12; the results are shown in Fig. 4c,
d and Table 4.
Again, the most stable conformers are the ones with
facing charged groups. Compound 15 has a broader
spectrum of available conformers, and the one nearest the
global minimum (+1.67 kcal) is highly superimposable
with the crystallographic coordinates of thio-THIP 4b [13]
(Fig. 5c, RMSD=0.19 Å). It is noteworthy that examining
the PES of 14 the minima corresponding to the THIP-like
conformations are much less shallow than in the PES of 1
and 15, and their energy relative to the global minimum is
well above the 5-kcal threshold. The conformation nearest
to the global minimum (+4.68 kcal) is very similar to the
one found for 12 (RMSD=0.80 from 4a). This finding
indicates that removing the steric hindrance represented by
the methyl group in AEMI is not sufficient to stabilise a
THIP-like conformation such as the one assumed by the
oxadiazole analogue 1. Therefore, the capability of assum-
ing the bioactive conformation seems to be warranted by
the peculiar electronic features of the 1,2,5-(oxa,thia)
diazole systems with respect to the isoxazole ring. To
further investigate this point, the electrostatic potential was
calculated from the QM-derived wavefunction and mapped
on the isodensity surface (Fig. 6). The negative electrostatic
potential in correspondence of the nitrogen atom in 5-
position on the 1,2,5-oxadiazole ring stabilises the THIP-
like conformation, allowing a strong electrostatic interaction
with the protonated amino group. On the contrary, the
corresponding isoxazolic methine group gives rise to an
almost neutral potential, so that THIP-like conformers are not
energetically accessible. The negative potential on the
nitrogen atom is present in the 1,2,5-thiadiazole ring too, in
spite of the much lower electronegativity of the sulphur atom.
On the basis of these results, we wanted to verify if the
lower activity of derivative 2 and the inactivity of 3 could
be explained as well with their conformational preferences.
Since the number of possible conformations is much higher
due to the increased number of rotatable bonds, the PES
torsional scan was accomplished by a stochastic MM
search, then the conformations in a 5-kcal range from the
global minimum underwent unconstrained optimisation by
the same QM methods employed for the lower homologues.
The results are reported in Table 5.
Once more, for compound 2 the global minimum is
represented by a conformer in which the ionised groups
interact closely. The nearest conformational minimum
(+1.95 kcal) is characterised by an extended conformation
of the 3-aminopropyl chain. At 2.42 kcal above the global
minimum a conformer is found which is fairly superim-
posable with 4a (Fig. 5b, RMSD=0.27 Å, calculated over
the ring atoms and the charged terminals, since the number
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of side chain carbons differs). The less precise match with
4a, the existence of a low-energy extended conformer and
the more unfavourable entropic term due to the loss of an
additional torsional degree of freedom upon binding
account for the lower activity of 2 with respect to 1. When
compound 3 was examined, four conformers were found
(the global minimum and the ones lying respectively 0.16,
0.99, 2.14 kcal above it) which are more stable than the
putative THIP-like bioactive one (+4.15 kcal, RMSD=0.38 Å
from 4a, calculated over the ring atoms and the charged
terminals); at the same time, the side chain is not long
enough to hypothesise a binding mode similar to that of 4-
PIOL 5a [10]. Therefore, the very low probability of
assuming the bioactive conformation together with the
increased molecular volume and an absolutely unfavourable
entropic contribution account for the lack of activity of
compound 3.
Gàlvez-Ruano and co-workers noticed that intramolecular
interactions between oppositely charged groups in GABAA
ligands can be overestimated by implicit solvent models
[26]. To check this possibility, we performed another
conformational search through molecular dynamics, this
time modelling solvent explicitly (see Methods for details).
The potential energies of the solvated conformers thus
obtained are too dependent on the bulk water coordinates,
and therefore are not easily comparable; careful solvent
sampling and energy averaging over a large number of
configurations should be carried out to get reliable figures.
Such a task would have been very time-consuming and not
really necessary for our purposes; instead, we decided to
rank the conformers according to their potential energy
calculated with the GB/SA approach, after stripping off the
water molecules. The results for compound 1 are reported in
Table 6.
A larger number of stable conformers were found with
this kind of search, since the presence of the solvent
molecules complicates the PES allowing the existence of
more local minima. The relative energy ranking is actually
inverted with respect to the one found by the QM
systematic search, with the most stable conformers being
the ones with the side chain in an extended configuration,
and the least stable those with charged groups facing each
other. However, also in this case two THIP-like conformers
are found in the middle (heavy-atom RMSD 0.26 and 0.32
from THIP, respectively), with almost identical geometries
with respect to the one found by QM methods; their energy
relative to the global minimum is about +1.5 kcal, so the
validity of the discussion made previously is confirmed. Tables
7, 8, 9, 10, 11 (Electronic supplementary material) report all
conformations for compounds 2, 3, 12, 14, 15. Also in the
case of compound 2, the extended conformers are energeti-
cally more favourable than the ones with facing charged
groups, but again two THIP-like conformers are found
(RMSD=0.22, E=+2.06 kcal; RMSD=0.40, E=+0.76 kcal)
as in the MM GB/SA stochastic search. In the case of
compound 3 the results justify even more the feeble affinity
for the receptor, since no THIP-like conformers are found, but
only many conformers with the side chain in an extended
configuration. For both isoxazolic models 12, 14, the same
picture as in the QM search was found, with no THIP-like
conformers and folded conformers more stable than the
extended ones. Moving to the thiadiazolic model 15, again
a THIP-like conformer can be recognised (RMSD=0.49,
E=+1.25 kcal), together with mixed folded and extended
conformers with energies between the global minimum and
+1.08 kcal. On the whole, the MD search in explicit solvent
validated the results obtained with the QM C-PCM method
and the MM stochastic search about the distinct conforma-
tional preferences of (oxa,thia)diazolic ligands compared to
the isoxazolic analogues 12, 14. Implicit solvent models,
both QM and MM, confirm their tendency towards over-
estimating intramolecular electrostatic interactions when
dealing with zwitterionic molecules.
Summary
Geometric and electronic features of the 1,2,5-oxadiazol-3-
ol ring system have been analysed with theoretical methods
and compared with the carboxy group as well as with its
isoxazol counterpart, in order to demonstrate non-classical
isosterism. While acidity and geometries are quite compa-
rable, the electronic distribution displays rather marked
differences. A conformational study has been carried out to
elucidate the putative bioactive conformation of compounds
1, 2, which are the only examples of pentatomic hetero-
cycles bearing a flexible side chain in the position vicinal to
the hydroxyl group displaying agonist activity at the
GABAA receptor. For both of them, an energetically
accessible conformer has been identified which closely
mimics the crystallographic conformation of THIP. The
same conformer is not energetically accessible for the
isoxazole analogues 12, 14, while appears to be available to
the 1,2,5-thiadiazole analogue 15. The reason of the
conformational profile shown by the 1,2,5-(oxa,thia)diazole
derivatives seems to rely largely in the electrostatic
potential at the nitrogen atom in position 5 on the ring.
Compound 4b, the sulphur analogue of THIP, was found to
be 300 times less active than 4a; a steric clash between the
bulkier sulphur atom and the receptor has been invoked to
explain this behaviour [6]. The synthesis and pharmaco-
logical characterisation of 15 would allow to verify if the
same picture holds true or if the greater flexibility of the
side chain allows it to avoid the aforementioned steric
clash, and possibly display higher affinity than 1 due to the
increase in hydrophobicity, as in the case of 5b with respect
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to 5a [6], and to the higher propensity to assume the
bioactive conformation (only 1.67 kcal above the global
minimum instead of 3.18). The conformational analysis
allowed rationalising the lower activity of 2 and the
inactivity of 3 as well. Therefore, ω-aminopropyl-1,2,5-
oxadiazolols 1, 2 have proved to possess a distinct
conformational profile with respect to the isoxazolol
analogues, which confers them affinity for the GABAA
receptor. The elucidation of the electronic properties of
1,2,5-oxadiazolols can prove useful in the design of new
ligands employing this ring system as a bioisoster of the
carboxy group.
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